These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1693317)

  • 1. Palliative chemo-radiotherapy with ifosfamide and epirubicin as first-line treatment for high-risk metastatic breast cancer. Results of a prospective multicenter trial.
    Lange OF; Scheef W; Haase KD; Heckmann M; Leyendecker R; Urban G; Zegners G
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S74-7. PubMed ID: 1693317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative radio-chemotherapy with ifosfamide and BCNU for breast cancer patients with cerebral metastases. A 5-year experience.
    Lange OF; Scheef W; Haase KD
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S78-80. PubMed ID: 1693318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metastatic breast cancer with the combination of ifosfamide, epirubicin and 5-fluorouracil.
    Ghavamzadeh A
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S66-8. PubMed ID: 2347052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin and ifosfamide in patients with refractory breast cancer and other metastatic solid tumours.
    Hoffmann W; Weidmann B; Migeod F; Könner J; Seeber S
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S69-70. PubMed ID: 2347053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epirubicin and ifosfamide in metastatic breast cancer.
    Becher R; Kloke O; Hayungs J; Hartwich G; Bartels H; Szanto J; Wolf E; Illiger HJ; Halabi S; Rieche K; Hering KG; Ohl S; DeDycker R; Huhn R; Fischedick AR; Höfeler H; Pielken HJ; Hawig I; Hirche H; Seeber S
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):28-33. PubMed ID: 8711499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer.
    Haas R; Schmid H; Hahn U; Hohaus S; Goldschmidt H; Murea S; Kaufmann M; Wannenmacher M; Wallwiener D; Bastert G; Hunstein W
    Eur J Cancer; 1997 Mar; 33(3):372-8. PubMed ID: 9155519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer.
    Gurney H; Harnett P; Stuart-Harris R; Kefford R
    Eur J Cancer; 1995 Oct; 31A(11):1773-7. PubMed ID: 8541098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local hyperthermia, radiation, and chemotherapy in recurrent breast cancer is feasible and effective except for inflammatory disease.
    Feyerabend T; Wiedemann GJ; Jäger B; Vesely H; Mahlmann B; Richter E
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1317-25. PubMed ID: 11286840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.
    Jacot W; Pujol JL; Chakra M; Molinier O; Bozonnat MC; Gervais R; Quantin X
    Lung Cancer; 2012 Feb; 75(2):213-6. PubMed ID: 21831476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancer.
    Lind MJ; Gumbrell L; Cantwell BM; Millward MJ; Simmonds D; Proctor M; Chapman F; McCann E; Middleton I; Calvert AH
    Br J Cancer; 1995 Mar; 71(3):610-3. PubMed ID: 7533518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
    Toma S; Palumbo R; Canavese G; Albanese E; Cantoni E; Barisone A; Reggiardo G; Rosso R; Santi L
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
    Stemmler HJ; Salat C; Lindhofer H; Menzel H; Untch M; Kahlert S; Konecny G; Sauer H; Ledderose G; Heinemann V; Kolb HJ
    Anticancer Res; 2005; 25(4):3047-54. PubMed ID: 16080564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory breast cancer: enhanced local control with hyperfractionated radiotherapy and infusional vincristine, ifosfamide and epirubicin.
    Gurney H; Harnett P; Kefford R; Boyages J
    Aust N Z J Med; 1998 Jun; 28(3):400-2. PubMed ID: 9673758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.
    Kiraz S; Baltali E; Güler N; Barista I; Benekli M; Celik I; Güllü IH; Kars A; Tekuzman G; Firat D
    J Chemother; 1996 Aug; 8(4):310-4. PubMed ID: 8873839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pneumo- and cardiotoxic side effects following combination chemotherapy with epirubicin and ifosfamide].
    Franzen D; Pöhler E; Hilger HH
    Med Klin (Munich); 1990 Mar; 85 Suppl 1():133-6, 170. PubMed ID: 2160577
    [No Abstract]   [Full Text] [Related]  

  • 17. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M; Erturk D
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
    Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose- intensified, preoperative and adjuvant chemotherapy in patients with T3- and T4- breast cancer: toxicity, clinical and pathological remission.
    Blohmer JU; Paepke S; Kissner L; Elling D; Fleige B; Grineisen Y; Lichtenegger W
    Zentralbl Gynakol; 1999; 121(11):522-5. PubMed ID: 10612219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.